{"url_path":"/sec/ctor/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-057841-index.html","accession_number":"0001213900-26-057841","cik":"0001851484","ticker":"CTOR","issuer_name":"CITIUS ONCOLOGY, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-057841-index.html","primary_entity_key":"0001851484","primary_entity_name":"CITIUS ONCOLOGY, INC."},"word_count":1181,"has_tables":true,"body_markdown":"** **\n\n**Item 6. Exhibits.**\n\n \n\n4.1\n \n[Form of Warrant issued on May 6, 2026 (incorporated by reference to Exhibit 4.1 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex4-1.htm)\n\n \n \n \n\n4.2\n \n[Form of Placement Agent Warrant issued on May 6, 2026 (incorporated by reference to Exhibit 4.2 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex4-2.htm)\n\n \n \n \n\n4.3\n \n[Form of Lender Warrant issued on May 6, 2026 (incorporated by reference to Exhibit 4.3 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex4-3.htm)\n\n \n \n \n\n10.1\n \n[Form of Warrant Inducement Agreement, dated as of May 5, 2026, by and between Citius Oncology, Inc. and the holder signatory thereto (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex10-1.htm)\n\n \n \n \n\n10.2\n \n[Form of Warrant Amendment Agreement, dated as of May 5, 2026, by and between Citius Oncology, Inc. and the holder signatory thereto (incorporated by reference to Exhibit 10.2 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex10-2.htm)\n\n \n \n \n\n10.3\n \n[Third Amendment to Promissory Note, dated May 4, 2026, by and between Citius Oncology, Inc. and Citius Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.3 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex10-3.htm)\n\n \n \n \n\n10.4\n \n[Loan and Security Agreement, dated as of May 5, 2026, among the Company, Citius Sub, the Agent and the Lenders (incorporated by reference to Exhibit 10.4 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex10-4.htm)\n\n \n \n \n\n10.5\n \n[Supplement to Loan and Security Agreement, dated as of May 5, 2026, among the Company, Citius Sub, the Agent and the Lenders (incorporated by reference to Exhibit 10.5 to the Form 8-K filed on May 6, 2026).](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex10-5.htm)\n\n \n \n \n\n10.6\n \n[Subordination Agreement, dated as of May 5, 2026, among the Parent, the Agent and the Company (incorporated by reference to Exhibit 10.6 to the Form 8-K filed on May 6, 2026).+](https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea028929701ex10-6.htm)\n\n \n \n \n\n31.1\n \n[Certification of the Principal Executive Officer pursuant to Exchange Act Rule 13a-14(a).*](ea029055301ex31-1.htm)\n\n \n \n \n\n31.2\n \n[Certification of the Principal Financial Officer pursuant to Exchange Act Rule 13a-14(a).*](ea029055301ex31-2.htm)\n\n \n \n \n\n32.1\n \n[Certification of the Principal Executive and Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.*](ea029055301ex32-1.htm)\n\n \n \n \n\nEX-101.INS\n \nInline XBRL Instance Document*\n\n \n \n \n\nEX-101.SCH\n \nInline XBRL Taxonomy Extension\nSchema Document*\n\n \n \n \n\nEX-101.CAL\n \nInline XBRL Taxonomy Extension\nCalculation Linkbase Document*\n\n \n \n \n\nEX-101.DEF\n \nInline XBRL Taxonomy Extension\nDefinition Linkbase Document*\n\n \n \n \n\nEX-101.LAB\n \nInline XBRL Taxonomy Extension\nLabel Linkbase Document*\n\n \n \n \n\nEX-101.PRE\n \nInline XBRL Taxonomy Extension\nPresentation Linkbase Document*\n\n \n \n \n\nEX-104\n \nCover Page Interactive\nData File (formatted as Inline XBRL and contained in Exhibit 101)*\n\n \n\n*\nFiled herewith.\n\n+\nCertain portions of this\nexhibit that are not material and would be competitively harmful if publicly disclosed have been redacted pursuant to Item 601(b)(10)(iv)\nof Regulation S-K. Copies of the unredacted exhibit will be furnished to the SEC upon request.\n\n \n\n28\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \n**CITIUS ONCOLOGY, INC.**\n\n \n \n \n\nDate: May 15, 2026\nBy:\n/s/ *Leonard\nMazur*\n\n \n \nLeonard Mazur\n\n \n \n\nChief Executive Officer\n\n(Principal Executive Officer)\n\n \n \n \n\nDate: May 15, 2026\nBy:\n/s/ *Jaime\nBartushak*\n\n \n \nJaime Bartushak\n\n \n \n\nChief Financial Officer\n\n(Principal Financial and Accounting Officer)\n\n \n\n29\n\n \n\n0001851484\nfalse\n2026\nQ2\n--09-30\n\n0001851484\n\n2025-10-01\n2026-03-31\n\n0001851484\n\n2026-05-14\n\n0001851484\n\n2026-03-31\n\n0001851484\n\n2025-09-30\n\n0001851484\n\nus-gaap:RelatedPartyMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:RelatedPartyMember\n\n2025-09-30\n\n0001851484\n\n2026-01-01\n2026-03-31\n\n0001851484\n\n2025-01-01\n2025-03-31\n\n0001851484\n\n2024-10-01\n2025-03-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2025-09-30\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2025-09-30\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-09-30\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2025-09-30\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2025-10-01\n2025-12-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2025-10-01\n2025-12-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-10-01\n2025-12-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2025-10-01\n2025-12-31\n\n0001851484\n\n2025-10-01\n2025-12-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2025-12-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0001851484\n\n2025-12-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2024-09-30\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2024-09-30\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-09-30\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2024-09-30\n\n0001851484\n\n2024-09-30\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2024-10-01\n2024-12-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2024-10-01\n2024-12-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-10-01\n2024-12-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2024-10-01\n2024-12-31\n\n0001851484\n\n2024-10-01\n2024-12-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2024-12-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0001851484\n\n2024-12-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2025-03-31\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001851484\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0001851484\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0001851484\n\n2025-03-31\n\n0001851484\n\nctor:CitiusPharmaMember\n\n2024-08-12\n\n0001851484\n\nctor:CitiusPharmaMember\n\n2026-03-31\n\n0001851484\n\nctor:TenXMember\n\n2026-03-31\n\n0001851484\n\nctor:CitiusPharmaMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001851484\n\nctor:LoanMember\nus-gaap:SubsequentEventMember\n\n2026-05-06\n\n0001851484\n\nsrt:MinimumMember\nus-gaap:SubsequentEventMember\n\n2026-05-06\n\n0001851484\n\nsrt:MaximumMember\nus-gaap:SubsequentEventMember\n\n2026-05-06\n\n0001851484\n\nsrt:ScenarioForecastMember\n\n2026-12-31\n\n0001851484\n\nsrt:MaximumMember\n\n2026-03-31\n\n0001851484\n\nsrt:MinimumMember\n\n2026-03-31\n\n0001851484\n\nctor:SalesAllowancesMember\n\n2026-03-31\n\n0001851484\n\nctor:PrepaidExpensesMember\n\n2026-03-31\n\n0001851484\n\nctor:LYMPHIRMember\n\n2026-03-31\n\n0001851484\n\nctor:LYMPHIRMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nctor:LYMPHIRMember\n\n2025-01-01\n2025-03-31\n\n0001851484\n\nctor:LYMPHIRMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nctor:LYMPHIRMember\n\n2024-10-01\n2025-03-31\n\n0001851484\n\nus-gaap:InProcessResearchAndDevelopmentMember\n\n2026-03-31\n\n0001851484\n\nctor:DrReddysMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nsrt:MinimumMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nsrt:MaximumMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nctor:DrReddysMember\nctor:AssetPurchaseAgreementMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nctor:LicenseAgreementMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nus-gaap:LicensingAgreementsMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\n2025-07-15\n\n0001851484\n\nus-gaap:LicensingAgreementsMember\nctor:EisaiMember\n\n2025-07-15\n\n0001851484\n\n2025-12-15\n\n0001851484\n\nus-gaap:LicensingAgreementsMember\nctor:EisaiMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\n2024-08-05\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2024-08-05\n\n0001851484\n\nus-gaap:PreferredStockMember\n\n2024-08-05\n\n0001851484\n\nsrt:MinimumMember\nus-gaap:CommonStockMember\n\n2025-04-07\n\n0001851484\n\nsrt:MaximumMember\nus-gaap:CommonStockMember\n\n2025-04-07\n\n0001851484\n\nus-gaap:CommonStockMember\nus-gaap:IPOMember\n\n2025-07-17\n2025-07-17\n\n0001851484\n\nus-gaap:CommonStockMember\nus-gaap:IPOMember\n\n2025-07-17\n\n0001851484\n\nus-gaap:WarrantMember\n\n2025-07-17\n\n0001851484\n\nus-gaap:WarrantMember\nus-gaap:IPOMember\n\n2025-12-10\n\n0001851484\n\nus-gaap:CommonStockMember\n\n2025-07-17\n2025-07-17\n\n0001851484\n\n2025-07-17\n2025-07-17\n\n0001851484\n\nus-gaap:WarrantMember\nus-gaap:InvestorMember\n\n2025-07-17\n2025-07-17\n\n0001851484\n\nus-gaap:WarrantMember\nus-gaap:InvestorMember\n\n2025-12-08\n2025-12-08\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\n\n2025-07-17\n\n0001851484\n\nus-gaap:WarrantMember\n\n2025-07-17\n2025-07-17\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\n\n2025-07-17\n2025-07-17\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nus-gaap:CommonStockMember\n\n2025-07-17\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nus-gaap:CommonStockMember\n\n2025-07-17\n2025-07-17\n\n0001851484\n\nus-gaap:CommonStockMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n2025-09-10\n\n0001851484\n\nus-gaap:CommonStockMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n\n0001851484\n\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n\n0001851484\n\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n2025-09-10\n\n0001851484\n\nus-gaap:WarrantMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n\n0001851484\n\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nus-gaap:WarrantMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nus-gaap:WarrantMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n2025-09-10\n\n0001851484\n\nus-gaap:WarrantMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-08\n2025-12-08\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n2025-09-10\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nus-gaap:CommonStockMember\nctor:SeptemberTwoThousandTwentyFiveOfferingMember\n\n2025-09-10\n\n0001851484\n\nus-gaap:CommonStockMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n2025-12-10\n\n0001851484\n\nus-gaap:CommonStockMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nus-gaap:WarrantMember\nus-gaap:CommonStockMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:PrefundedWarrantsMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n2025-12-10\n\n0001851484\n\nctor:PrefundedWarrantsMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:PrefundedWarrantsMember\nus-gaap:CommonStockMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n2025-12-10\n\n0001851484\n\nctor:December2025OfferingInvestors1Member\n\n2026-03-31\n\n0001851484\n\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nus-gaap:WarrantMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:InvestorsWarrantsMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:InvestorsWarrantsMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n2025-12-10\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nus-gaap:CommonStockMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n\n0001851484\n\nctor:PlacementAgentWarrantsMember\nctor:DecemberTwoThousandTwentyFiveOfferingMember\n\n2025-12-10\n2025-12-10\n\n0001851484\n\nctor:StockPlansMember\n\n2023-04-29\n\n0001851484\n\nctor:StockPlansMember\n\n2024-08-02\n\n0001851484\n\nctor:TwoThousandTwentyFourPlanMember\n\n2025-10-27\n\n0001851484\n\nctor:StockPlansMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nctor:StockPlansMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nctor:StockPlansMember\n\n2025-01-01\n2025-03-31\n\n0001851484\n\nctor:StockPlansMember\n\n2024-10-01\n2025-03-31\n\n0001851484\n\nctor:StockPlansMember\n\n2026-03-31\n\n0001851484\n\nsrt:BoardOfDirectorsChairmanMember\nus-gaap:RestrictedStockMember\n\n2025-09-19\n2025-09-19\n\n0001851484\n\nus-gaap:RestrictedStockMember\n\n2025-09-19\n2025-09-19\n\n0001851484\n\nus-gaap:RestrictedStockMember\nus-gaap:CommonStockMember\n\n2025-09-19\n2025-09-19\n\n0001851484\n\nus-gaap:RestrictedStockMember\n\n2026-03-24\n2026-03-24\n\n0001851484\n\nus-gaap:RestrictedStockMember\nus-gaap:CommonStockMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nus-gaap:RestrictedStockMember\n\n2026-01-01\n2026-03-31\n\n0001851484\n\nus-gaap:RestrictedStockMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nus-gaap:RestrictedStockMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001851484\n\nus-gaap:WarrantMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\n2025-12-10\n\n0001851484\n\n2026-09-29\n\n0001851484\n\n2026-09-30\n2026-09-30\n\n0001851484\n\nctor:July2025OfferingInvestorsMember\n\n2026-03-31\n\n0001851484\n\nctor:July2025OfferingAgentMember\n\n2026-03-31\n\n0001851484\n\nctor:July2025PriorOfferingAgentMember\n\n2026-03-31\n\n0001851484\n\nctor:September2025OfferingInvestorsMember\n\n2026-03-31\n\n0001851484\n\nctor:September2025OfferingAgentMember\n\n2026-03-31\n\n0001851484\n\nctor:September2025PriorOfferingAgentMember\n\n2026-03-31\n\n0001851484\n\nctor:December2025OfferingInvestors2Member\n\n2026-03-31\n\n0001851484\n\nctor:December2025PlacementOfferingAgentMember\n\n2026-03-31\n\n0001851484\n\nctor:December2025PriorOfferingAgentMember\n\n2026-03-31\n\n0001851484\n\nctor:StockPlanOptionsOutstandingMember\n\n2026-03-31\n\n0001851484\n\nctor:RestrictedStockAwardsMember\n\n2026-03-31\n\n0001851484\n\nctor:StockPlanSharesAvailableForFutureGrantsMember\n\n2026-03-31\n\n0001851484\n\nctor:WarrantsOutstandingMember\n\n2026-03-31\n\n0001851484\n\nsrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember\n\n2026-02-01\n2026-02-28\n\n0001851484\n\nsrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember\n\n2025-10-01\n2026-03-31\n\n0001851484\n\nsrt:ScenarioForecastMember\n\n2027-12-31\n\n0001851484\n\nctor:UnsecuredPromissoryNoteMember\n\n2024-08-16\n\n0001851484\n\n2024-08-16\n2024-08-16\n\n0001851484\n\nus-gaap:CommonStockMember\nus-gaap:SubsequentEventMember\n\n2026-04-22\n\n0001851484\n\nus-gaap:SubsequentEventMember\n\n2026-04-22\n\n0001851484\n\nus-gaap:CommonStockMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n\n0001851484\n\n2025-07-16\n\n0001851484\n\n2025-09-10\n\n0001851484\n\nus-gaap:SubsequentEventMember\n\n2026-05-05\n\n0001851484\n\nus-gaap:CommonStockMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001851484\n\nus-gaap:SubsequentEventMember\nctor:LoanAgreementMember\n\n2026-05-05\n\n0001851484\n\nus-gaap:LoansMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n\n0001851484\n\nsrt:MinimumMember\nus-gaap:LoansMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001851484\n\nsrt:MaximumMember\nus-gaap:LoansMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001851484\n\nus-gaap:LoansMember\nus-gaap:SubsequentEventMember\n\n2026-05-05\n2026-05-05\n\n0001851484\n\nus-gaap:SubsequentEventMember\n\n2026-05-04\n\n0001851484\n\nctor:NotePayableMember\nus-gaap:SubsequentEventMember\n\n2026-05-04\n\nxbrli:shares\n\niso4217:USD\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure"}